Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting t cell function - Crane, C; Panner, A; Pieper, R O; Arbise, J; Parsa, A T (J Immunother, 2009)